Transfusion-related acute lung injury: Reports to the French Hemovigilance Network 2007 through 2008

Transfusion

Volumn 51, Issue 10, 2011, Pages 2102-2110

  Ozier, Yves ^{a,b,c,d,e,f,g,h,i}   Muller, Jean Yves ^{a,b,c,d,e,f,g,h,i}   Mertes, Paul Michel ^{a,b,c,d,e,f,g,h,i}   Renaudier, Philippe ^{a,b,c,d,e,f,g,h,i}   Aguilon, Philippe ^{a,b,c,d,e,f,g,h,i}   Canivet, Nathalie ^{a,b,c,d,e,f,g,h,i}   Fabrigli, Patrick ^{a,b,c,d,e,f,g,h,i}   Rebibo, Danielle ^{a,b,c,d,e,f,g,h,i}   Tazerout, Mahdi ^{a,b,c,d,e,f,g,h,i}   Trophilme, Catherine ^{a,b,c,d,e,f,g,h,i}   Willaert, Béatrice ^{a,b,c,d,e,f,g,h,i}   Caldani, Cyril ^{a,b,c,d,e,f,g,h,i}  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e Military Teaching Hospital Sainte Anne   (France)

^f UNIVERSITY HOSPITAL OF NICE   (France)

^g ETABLISSEMENT FRANÇAIS DU SANG   (France)

^h Agence régionale de l'hospitalisation de Midi Pyrénées   (France)

ⁱ AFSSAPS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; FRESH FROZEN PLASMA; HLA ANTIBODY; SOLVENT; THROMBOCYTE CONCENTRATE;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CAUSE OF DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; ERYTHROCYTE CONCENTRATE; FEMALE; FRANCE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; OBSTETRICS; PLASMA VOLUME; POSTOPERATIVE PERIOD; RESPIRATORY FAILURE; RISK ASSESSMENT; SEROLOGY; THROMBOCYTOPHERESIS; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; FRANCE; HLA ANTIGENS; HUMANS; INCIDENCE; ISOANTIBODIES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 80054744172     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03073.x     Document Type: Article

References (33)

1. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB,. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007; 176: 886-91. (Pubitemid 350097078)
2. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D,. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-6.
3. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P,. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-89. (Pubitemid 39644064)
4. Faber JC,. Worldwide overview of existing haemovigilance systems. Transfus Apher Sci 2004; 31: 99-110.
5. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM,. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-52.
6. van Stein D, Beckers EA, Sintnicolaas K, Porcelijn L, Danovic F, Wollersheim JA, Brand A, van Rhenen DJ,. Transfusion-related acute lung injury reports in the Netherlands: an observational study. Transfusion 2010; 50: 213-20.
7. Keller-Stanislawski B, Reil A, Gunay S, Funk MB,. Frequency and severity of transfusion-related acute lung injury-German haemovigilance data (2006-2007). Vox Sang 2010; 98: 70-7.
8. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Herve P,. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002; 42: 1356-64.
9. Terasaki PI, McClelland JD,. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.
10. Lalezari P,. Neutrophil antigens: immunology and clinical implications. Prog Clin Biol Res 1977; 13: 209-25.
11. Verheugt FW, von dem Borne AE, Decary F, Engelfriet CP,. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol 1977; 36: 533-44. (Pubitemid 8159829)
12. Bux J, Kober B, Kiefel V, Mueller-Eckhardt C,. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens. Transfus Med 1993; 3: 157-62.
13. Bux J, Chapman J,. Report on the second international granulocyte serology workshop. Transfusion 1997; 37: 977-83.
14. Bunce M, Fanning GC, Welsh KI,. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 45: 81-90.
15. Gajic O, Gropper MA, Hubmayr RD,. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006; 34: S109-13. (Pubitemid 43670476)
16. Vlaar AP, Binnekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, Juffermans NP,. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med 2010; 38: 771-8.
17. Nathens AB,. Massive transfusion as a risk factor for acute lung injury: association or causation? Crit Care Med 2006; 34: S144-50. (Pubitemid 43670482)
18. Marik PE, Corwin HL,. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med 2008; 36: 3080-4.
19. Finlay HE, Cassorla L, Feiner J, Toy P,. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol 2005; 124: 601-9. (Pubitemid 41395642)
20. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-7. (Pubitemid 16174471)
21. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62. (Pubitemid 36077563)
22. Quaranta JF, Berthier F, Courbil R, Courtois F, Chenais F, Waller C, Leconte des Floris MF, Andreu G, Fontaine O, Le Niger C, Puntous M, Mercadier A, Nguyen L, Pelissier E, Gondrexon G, Staccini P,. [Who are the recipients of labile blood products? A multicenter nation-wide study-a "donation day." Blood banks, health facilities.]. Transfus Clin Biol 2009; 16: 21-9.
23. Wells AW, Llewelyn CA, Casbard A, Johnson AJ, Amin M, Ballard S, Buck J, Malfroy M, Murphy MF, Williamson LM,. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med 2009; 19: 315-28.
24. Vlaar AP, Wortel K, Binnekade JM, van Oers MH, Beckers E, Gajic O, Schultz MJ, Juffermans NP,. The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines. Transfusion 2010; 50: 443-51.
25. Li G, Kojicic M, Reriani MK, Fernandez Perez ER, Thakur L, Kashyap R, Van Buskirk CM, Gajic O,. Long-term survival and quality of life after transfusion associated pulmonary edema in critically ill medical patients. Chest 2010; 137: 783-9.
26. Eder AF, Benjamin RJ,. TRALI risk reduction: donor and component management strategies. J Clin Apher 2009; 24: 122-9.
27. Murphy MF, Navarrete C, Massey E,. Donor screening as a TRALI risk reduction strategy. Transfusion 2009; 49: 1779-82.
28. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V,. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med 2004; 14: 157-64. (Pubitemid 38623078)
29. Vlaar AP, Binnekade JM, Schultz MJ, Juffermans NP, Koopman MM,. Preventing TRALI: ladies first, what follows? Crit Care Med 2008; 36: 3283-4; author reply 4.
30. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, Dodd RY, Benjamin RJ,. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007; 47: 599-607. (Pubitemid 46449614)
31. Flesland O,. A comparison of complication rates based on published haemovigilance data. Intensive Care Med 2007; 33 Suppl 1: S17-21. (Pubitemid 47222321)
32. Sachs U, Kauschat D, Bein G,. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005; 45: 1628-31.
33. Sinnott P, Bodger S, Gupta A, Brophy M,. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet 2004; 31: 271-4. (Pubitemid 39572286)